Compound K Production: Achievements and Perspectives
Abstract
:1. Introduction
2. Biological Significance in Humans
3. Biosynthesis Approaches for Compound K
3.1. Ginseng Extraction and Chemical Synthesis
3.2. Enzymatically Synthesized CK
3.2.1. Enzyme from Native Microbes
3.2.2. Recombinant Enzymes
Strains | Transformation Pathway/Products | Buffer/ Medium | Temperature (Degree, °C) | pH | Time (Hours, h) | Titer/Efficiency | Ref. |
---|---|---|---|---|---|---|---|
β-glucosidase from native microbes | |||||||
Armillaria mellea | Rb1 → XVII/ Rd → F2 → CK | SA | 45–55 | 4.0–4.5 | 72–96 | 0.42 (mg mL−1) | [17] |
Armillaria mellea KACC 50013 | Rb2 → Rd → F2 → C-K, Rb2 → CO → CY → CK | SA | 45 | 4.5 | 96 | N/A | [38] |
Talaromyces purpureogenus | Rb1 → Rd → F2 → CK | MDES | 60 | 4.5 | 48 | 80.60% | [44] |
Lactobacillus pentosus DC10 | Rd → F2 → CK | SD | 30 | 7 | 72 | 97% | [46] |
Leuconostoc mesenteroides DC102 | Rb1 → XVII/Rd → F2 → CK | SD | 30 | 6.0–8.0 | 72 | 99% | [47] |
Leuconostoc citreum LH1 | Rb1 → Rd → F2 → CK | SD | 30 | 6 | 72 | 99% | [48] |
Stereum hirsutum JE0512 | Rb 1 → Rd → F2 → CK, Rc → Gyp XVII → Gyp LXXV → CK, Rb 2 → CO→ CY → CK, Rb 3 → CMx1 → CMx → CK | PDA | 25 | 6.8 | 10 days | 54.48 (mg g−1) | [50] |
Aspergillus niger XD101 | Rb1 → Rd → F2 → CK | AB | 50-60 | 4–5 | 72 | 94.4% | [51] |
Aspergillus tubingensis KCTC 14166 | Rc → Mc1 → Mc → CK Rb1 → Rd → F2 → CK Rb2 → CO → CY → CK | CB/PB | 55 | 4.0 | 20 | 418 (mg L−1 h−1) | [52] |
Fomitella fraxinea | Rb1 → Rd → F2 → CK Rc → Rd → F2 → CK Rc → CMc1 → CMc → CK | AB | 45 | 4.5 | 8 | N/A | [53] |
Paecilomyces Bainier sp. 229 | Rb1 → Rd → F2 → CK | FB | 45 | 3.5 | 24 | 84.30% | [56] |
Aspergillus niger g.848 | Rb1 → Rd → F2 → CK | AB | 45 | 5 | 18 | 69.5% | [57] |
Naringinase | |||||||
Gynostemma pentaphyllum | G-IV→ G-VIII → G-XII → CK (theory) | AB | 50 | 4.1 | 71 | 65.44% | [59] |
α-L-arabinofuranosidase and/or β-galactosidase with β-glucosidase | |||||||
α-L-arabinofuranosidase and β-galactosidase from Caldicellulosiruptor saccharolyticus; β-glucosidase from Sulfolobus acidocaldarius | Rc → Mc/Rd → CK Rb1 → Rd → CK Rb2 → Rd/CY → CK | CB/PB | 75 | 6.0 | 12 | 388 (mg L−1 h−1) | [68] |
14 | 328 (mg L−1 h−1) | ||||||
20 | 144 (mg L−1 h−1) | ||||||
Aspergillus tubingensis KCTC 14166 | Rb1 → Rd → F2 → CK, Rb2 → CO/Rd → CY/ F2 → CK Rc → Rd/CMc1 → F2/CMc → CK | PDB | 28 | 5.0 | 144 | 2.47 (g L−1) | [69] |
Enzyme recombinant expressed in E. coli | |||||||
bgpA coding for β-glucosidase from Terrabacter ginsenosidimutans | Rb1 → Gyp XVII → Gyp LXXV → CK | SD | 45 | 7 | N/A | N/A | [62] |
bgp3 coding for β-glucosidase from Microbacterium esteraromaticum | Rb1→ Rd → CK | SD | 40 | 7 | 1 | 77% (0.46 mg/mL) | [63] |
Rb2 → CY → CK | SD | 40 | 7 | 12 | 0.1 (mg mL−1) | [64] | |
β-glucosidase from Bifidobacterium breve ATCC 15700 | Rd → F2 → CK | CB/PB | 35 | 5.0 | 12 | 96% | [65] |
β-glucosidase from Sulfolobus solfataricus | Rb1 or Rb2 → Rd → F2 → CK, Rc → CMc → CK | Z buffer | 85 | 5.5 | 12 | 1.63 (mg mL−1) | [70] |
Rb1→ Rd→ CK, Rb2→ CY→ CK | CB | 85 | 5.5 | 3 | 0.53 (mg mL−1) | [66] | |
β-glucosidase from Pyrococcus furiosus | Rb1, Rb2, or Rc → Rd → CK | CB | 95 | 5.5 | 1 | 2.010 (mg L−1 h−1) | [67] |
Cytolase PCL5 | Rb3 → Rd → F2 → CK | N/A | 55.36 | 4.3 | 78.05 | 2.068 (mg mL−1) | [71] |
Enzyme recombinant expressed in Lactococcus lactis NZ9000 | |||||||
β-glucosidase genes (BglPm and BglBX10) from Paenibacillus mucilaginosus and Flavobacterium johnsoniae | Rb1 → Rd → F2 → CK | SD | N/A | 7.0 | 36 | 70% | [72] |
Enzyme recombinant expressed in Pichia pastoris | |||||||
β-glucosidase from Sulfolobus solfataricus | Rb1 → Rd → F2 → CK | AB | 80 | 6.0 | 30 | 82.5% | [73] |
Intestinal bacterial hydrolysis | |||||||
Eubacterium sp. A-44 | Rb1 → Rd → F2 → CK | GAM | 37 | 24 | 9.6 nmol min−1 mg−1 | [74] | |
7 | 4.8 ng mL−1 | ||||||
15 | 83.4 ng mL−1 | ||||||
Human gut bacteria | Rb1 → Rd → F2 → CK | BHI | 37 | 36 | 186.9 (µg mL−1) | [75] | |
Bifidobacterium K-103 | Rc → Rd → F2 → CK | GAM or TSTA | 37 | 24 | 62.3 (µg mL−1) | [76] | |
Bifidobacterium K-506 | Rc → Mb → F2/Mc → CK | GAM or TSTA | 37 | 24 | 6.5 (µg mL−1) | ||
Bacteroides JY-6 | Rc → Mb → F2/Mc → CK | GAM or TSTA | 37 | 24 | 6.7 (µg mL−1) | ||
CK production from endophytes | |||||||
Panax ginseng | |||||||
Arthrinium sp. GE 17-18 | Rb1 → Rd → F2 → CK | PDA | 30 | N/A | N/A | [77] | |
Panax notoginseng | |||||||
Fusarium oxysporum YMF1.02670 | Rb1 → Rd → F2 → CK | PDA | 28 | 12 days | 4 mg | [78] | |
Platycodon grandiflorum | |||||||
Luteibacter sp. JG09 | Rb1 → Rd → F2 → CK | LB | 30 | 7 days | 66.34% | [79] |
3.3. Biotransformation by the Human Intestinal Bacteria
3.4. Biotransformation by Endophytes
4. Metabolically Engineered Microbes
5. Conclusions and Future Perspectives
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Liu, J.; Zhang, X.; Yang, S.; Wang, S.; Liu, C.; Yang, B.; Li, Y.; Cai, T. Rapid identification of characteristic chemical constituents of Panax ginseng, Panax quinquefolius, and Panax japonicus using UPLC-Q-TOF/MS. J. Anal. Methods Chem. 2022, 2022, 6463770. [Google Scholar]
- Sun, Y.; Liu, X.; Fu, X.; Xu, W.; Guo, Q.; Zhang, Y. Discrepancy study of the chemical constituents of Panax Ginseng from different growth environments with UPLC-MS-based metabolomics strategy. Molecules 2023, 28, 2928. [Google Scholar] [CrossRef] [PubMed]
- Kim, J.H.; Yi, Y.S.; Kim, M.Y.; Cho, J.Y. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases. J. Ginseng Res. 2017, 41, 435–443. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, H.; Lu, X.; Hu, Y.; Fan, X. Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy. Pharmacol. Res. 2020, 161, 105263. [Google Scholar] [CrossRef]
- Hou, J.P. The chemical constituents of ginseng plants. Comp. Med. East West 1977, 5, 123–145. [Google Scholar] [CrossRef]
- Wang, H.P.; Wang, Z.J.; Du, J.; Lin, Z.Z.; Zhao, C.; Zhang, R.; Yin, Q.; Fan, C.L.; Peng, P.; Wang, Z.B. Comprehensive identification of ginsenosides in the roots and rhizomes of Panax ginseng based on their molecular features-oriented precursor ions selection and targeted MS/MS analysis. Molecules 2023, 28, 941. [Google Scholar] [CrossRef]
- Jin, S.; Jeon, J.H.; Lee, S.; Kang, W.Y.; Seong, S.J.; Yoon, Y.R.; Choi, M.K.; Song, I.S. Detection of 13 Ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, Compound K, 20(S)-Protopanaxadiol, and 20(S)-Protopanaxatriol) in human plasma and application of the analytical method to human pharmacokinetic studies following two week-repeated administration of red ginseng extract. Molecules 2019, 24, 2618. [Google Scholar]
- Peng, S.; Li, X.; Jiang, W.; Wang, Y.; Xiang, G.; Li, M.; Wang, Y.; Yang, Z.; Li, Y.; Liu, X.; et al. Identification of two key UDP-glycosyltransferases responsible for the ocotillol-type ginsenoside majonside-R2 biosynthesis in Panax vietnamensis var. fuscidiscus. Planta 2023, 257, 119. [Google Scholar] [CrossRef]
- Tong, Y.; Song, X.; Zhang, Y.; Xu, Y.; Liu, Q. Insight on structural modification, biological activity, structure-activity relationship of PPD-type ginsenoside derivatives. Fitoterapia 2022, 158, 105135. [Google Scholar] [CrossRef]
- Gao, X.Y.; Liu, G.C.; Zhang, J.X.; Wang, L.H.; Xu, C.; Yan, Z.A.; Wang, A.; Su, Y.F.; Lee, J.J.; Piao, G.C.; et al. Pharmacological properties of ginsenoside Re. Front. Pharmacol. 2022, 13, 754191. [Google Scholar] [CrossRef]
- Lu, J.; Wang, X.; Wu, A.; Cao, Y.; Dai, X.; Liang, Y.; Li, X. Ginsenosides in central nervous system diseases: Pharmacological actions, mechanisms, and therapeutics. Phytother. Res. 2022, 36, 1523–1544. [Google Scholar] [CrossRef]
- Chen, J.; Huang, Q.; Li, J.; Yao, Y.; Sun, W.; Zhang, Z.; Qi, H.; Chen, Z.; Liu, J.; Zhao, D.; et al. Panax ginseng against myocardial ischemia/reperfusion injury: A review of preclinical evidence and potential mechanisms. J. Ethnopharmacol. 2023, 300, 115715. [Google Scholar] [CrossRef]
- Hwang, E.; Park, S.Y.; Yin, C.S.; Kim, H.T.; Kim, Y.M.; Yi, T.H. Antiaging effects of the mixture of Panax ginseng and Crataegus pinnatifida in human dermal fibroblasts and healthy human skin. J. Ginseng Res. 2017, 41, 69–77. [Google Scholar] [CrossRef] [Green Version]
- Yi, Y.S. Potential benefits of ginseng against COVID-19 by targeting inflammasomes. J. Ginseng Res. 2022, 46, 722–730. [Google Scholar] [CrossRef]
- Sharma, A.; Lee, H.J. Ginsenoside compound K: Insights into recent studies on pharmacokinetics and health-promoting activities. Biomolecules 2020, 10, 1028. [Google Scholar] [CrossRef]
- Chu, L.L.; Bae, H. Bacterial endophytes from ginseng and their biotechnological application. J. Ginseng Res. 2020, 46, 1–10. [Google Scholar] [CrossRef]
- Upadhyaya, J.; Kim, M.J.; Kim, Y.H.; Ko, S.R.; Park, H.W.; Kim, M.K. Enzymatic formation of compound-K from ginsenoside Rb1 by enzyme preparation from cultured mycelia of Armillaria mellea. J. Ginseng Res. 2016, 40, 105112. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chu, L.L.; Montecillo, J.A.V.; Bae, H. Recent advances in the metabolic engineering of yeasts for ginsenoside biosynthesis. Front. Bioeng. Biotechnol. 2020, 8, 139. [Google Scholar] [CrossRef] [Green Version]
- Liu, J.; Wang, Y.; Yu, Z.; Lv, G.; Huang, X.; Lin, H.; Ma, C.; Lin, Z.; Qu, P. Functional mechanism of ginsenoside Compound K on tumor growth and metastasis. Integr. Cancer Ther. 2022, 21, 15347354221101203. [Google Scholar] [CrossRef]
- Tam, D.N.H.; Nam, N.H.; Cuong, N.T.K.; Hung, D.T.; Soa, D.T.; Altom, A.; Tran, L.; Elhadad, H.; Huy, N.T. Compound K: A systematic review of its anticancer properties and probable mechanisms. Fundam. Clin. Pharmacol. 2023. [Google Scholar] [CrossRef]
- Huang, Y.; Liu, H.; Zhang, Y.; Li, J.; Wang, C.; Zhou, L.; Jia, Y.; Li, X. Synthesis and biological evaluation of ginsenoside compound K derivatives as a novel class of LXRα activator. Molecules 2017, 22, 1232. [Google Scholar] [CrossRef] [PubMed]
- Ren, S.; Liu, R.; Wang, Y.; Ding, N.; Li, Y. Synthesis and biological evaluation of ginsenoside compound K analogues as a novel class of anti-asthmatic agents. Bioorganic Med. Chem. Lett. 2019, 29, 51–55. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.S.; Zhu, H.; Li, H.; Li, Y.; Zhao, B.; Jin, Y.H. Ginsenoside compound K inhibits nuclear factor-kappa B by targeting annexin A2. J. Ginseng Res. 2018, 43, 452–459. [Google Scholar] [CrossRef]
- Choi, E.; Kim, E.; Kim, J.H.; Yoon, K.; Kim, S.; Lee, J.; Cho, J.Y. AKT1-targeted proapoptotic activity of compound K in human breast cancer cells. J. Ginseng Res. 2019, 43, 692–698. [Google Scholar] [CrossRef] [PubMed]
- Zhou, L.; Zeng, X.; Liao, J.; Chen, L.; Ouyang, D. Gut microbiota modulates the protective role of ginsenoside compound K against sodium valproate-induced hepatotoxicity in rat. Front. Microbiol. 2022, 13, 936585. [Google Scholar] [CrossRef] [PubMed]
- Ryu, S.J.; Choi, J.; Lee, J.S.; Choi, H.S.; Yoon, K.Y.; Hwang, J.H.; Kim, K.J.; Lee, B.Y. Compound K inhibits the lipopolysaccharide-induced inflammatory responses in raw 264.7 cell line and zebrafish. Appl. Sci. 2018, 8, 924. [Google Scholar] [CrossRef] [Green Version]
- Baik, I.H.; Kim, K.H.; Lee, K.A. Antioxidant, anti-inflammatory and antithrombotic effects of ginsenoside compound K enriched extract derived from ginseng sprouts. Molecules 2021, 26, 4102. [Google Scholar] [CrossRef]
- Liu, T.; Zhu, L.; Wang, L. A narrative review of the pharmacology of ginsenoside Compound K. Ann. Transl. Med. 2022, 10, 234. [Google Scholar] [CrossRef]
- Pagonabarraga, J.; Alamo, C.; Castellanos, M.; Diaz, S.; Manzano, S. Depression in major neurodegenerative diseases and strokes: A critical review of similarities and differences among neurological disorders. Brain Sci. 2023, 13, 318. [Google Scholar] [CrossRef]
- Song, W.; Guo, Y.; Jiang, S.; Wei, L.; Liu, Z.; Wang, X.; Su, Y. Antidepressant effects of the ginsenoside metabolite compound K, assessed by behavioral despair test and chronic unpredictable mild stress model. Neurochem. Res. 2018, 43, 1371–1382. [Google Scholar] [CrossRef]
- Zong, W.; Zeng, X.; Chen, S.; Chen, L.; Zhou, L.; Wang, X.; Ouyang, D. Ginsenoside compound K attenuates cognitive deficits in vascular dementia rats by reducing the Aβ deposition. J. Pharmacol. Sci. 2019, 139, 223–230. [Google Scholar] [CrossRef]
- Zhou, L.; Zheng, Y.; Li, Z.; Bao, L.; Dou, Y.; Tang, Y.; Zhang, J.; Zhou, J.; Liu, Y.; Jia, Y.; et al. Compound K attenuates the development of atherosclerosis in ApoE(-/-) Mice via LXRα activation. Int. J. Mol. Sci. 2016, 17, 1054. [Google Scholar] [CrossRef]
- Kim, E.; Kim, D.; Yoo, S.; Hong, Y.H.; Han, S.Y.; Jeong, S.; Jeong, D.; Kim, J.H.; Cho, J.Y.; Park, J. The skin protective effects of compound K, a metabolite of ginsenoside Rb1 from Panax ginseng. J. Ginseng Res. 2018, 42, 218–224. [Google Scholar] [CrossRef]
- Hossain, M.A.; Kim, J.H. Possibility as role of ginseng and ginsenosides on inhibiting the heart disease of COVID-19: A systematic review. J. Ginseng Res. 2022, 46, 321–330. [Google Scholar] [CrossRef]
- Corbit, R.M.; Ferreira, J.F.; Ebbs, S.D.; Murphy, L.L. Simplified extraction of ginsenosides from American ginseng (Panax quinquefolius L.) for high-performance liquid chromatography-ultraviolet analysis. J. Agric. Food Chem. 2005, 53, 9867–9873. [Google Scholar] [CrossRef]
- Shin, B.K.; Kwon, S.W.; Park, J.H. Chemical diversity of ginseng saponins from Panax ginseng. J. Ginseng Res. 2015, 39, 287–298. [Google Scholar] [CrossRef] [Green Version]
- Yang, X.; Nambou, K.; Wei, L.; Hua, Q. Heterologous production of α-farnesene in metabolically engineered strains of Yarrowia lipolytica. Bioresour. Technol. 2016, 216, 1040–1048. [Google Scholar] [CrossRef]
- Kim, M.J.; Upadhyaya, J.; Yoon, M.S.; Ryu, N.S.; Song, Y.E.; Park, H.W.; Kim, Y.H.; Kim, M.K. Highly regioselective biotransformation of ginsenoside Rb2 into compound Y and compound K by β-glycosidase purified from Armillaria mellea mycelia. J. Ginseng Res. 2018, 42, 504–511. [Google Scholar] [CrossRef]
- Baeg, I.H.; So, S.H. The world ginseng market and the ginseng (Korea). J. Ginseng Res. 2013, 37, 1–7. [Google Scholar] [CrossRef] [Green Version]
- Han, B.H.; Park, M.H.; Han, Y.N.; Woo, L.K.; Sankawa, U.; Yahara, S.; Tanaka, O. Degradation of ginseng saponins under mild acidic conditions. Planta Med. 1982, 44, 146–149. [Google Scholar] [CrossRef]
- Chen, Y.J.; Nose, M.; Ogihara, Y. Alkaline cleavage of ginsenosides. Chem. Pharm. Bull. 1987, 35, 1653–1655. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shen, R.; Cao, X.; Laval, S.; Sun, J.; Yu, B. Synthesis of ocotillol-type ginsenosides. J. Org. Chem. 2016, 81, 10279–10294. [Google Scholar] [CrossRef] [PubMed]
- Shen, R.; Laval, S.; Cao, X.; Yu, B. Synthesis of Δ20-Ginsenosides Rh4, (20E)-Rh3, Rg6, and Rk1: A general approach to access dehydrated ginsenosides. J. Org. Chem. 2018, 83, 2601–2610. [Google Scholar] [CrossRef] [PubMed]
- Ma, Z.; Mi, Y.; Han, X.; Li, H.; Tian, M.; Duan, Z.; Fan, D.; Ma, P. Transformation of ginsenoside via deep eutectic solvents based on choline chloride as an enzymatic reaction medium. Bioprocess Biosyst. Eng. 2020, 43, 1195–1208. [Google Scholar] [CrossRef]
- Yang, X.D.; Yang, Y.Y.; Ouyang, D.S.; Yang, G.P. A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia 2015, 100, 208–220. [Google Scholar] [CrossRef]
- Quan, L.H.; Cheng, L.Q.; Kim, H.B.; Kim, J.H.; Son, N.R.; Kim, S.Y.; Jin, H.O.; Yang, D.C. Bioconversion of cinsenoside Rd into compound K by Lactobacillus pentosus DC101 isolated from Kimchi. J. Ginseng Res. 2010, 34, 288–295. [Google Scholar] [CrossRef] [Green Version]
- Quan, L.H.; Piao, J.Y.; Min, J.W.; Kim, H.B.; Kim, S.R.; Yang, D.U.; Yang, D.C. Biotransformation of ginsenoside Rb1 to prosapogenins, gypenoside XVII, ginsenoside Rd, ginsenoside F2, and compound K by Leuconostoc mesenteroides DC102. J. Ginseng Res. 2011, 35, 344–351. [Google Scholar] [CrossRef] [Green Version]
- Quan, L.H.; Piao, J.Y.; Min, J.W.; Yang, D.U.; Lee, H.N.; Yang, D.C. Bioconversion of ginsenoside Rb1 into compound K by Leuconostoc citreum LH1 isolated from Kimchi. Braz. J. Microbiol. 2011, 42, 1227–1237. [Google Scholar] [CrossRef]
- Ko, S.R.; Suzuki, Y.; Suzuki, K.; Choi, K.J.; Cho, B.G. Marked production of ginsenosides Rd, F2, Rg3, and compound K by enzymatic method. Chem. Pharm. Bull. 2007, 55, 1522–1527. [Google Scholar] [CrossRef] [Green Version]
- Yang, W.; Zhou, J.; Harindintwali, J.D.; Yu, X. Production of minor ginsenosides by combining Stereum hirsutum and cellulase. PLoS ONE. 2021, 16, e0255899. [Google Scholar] [CrossRef]
- Jiang, Y.; Li, W.; Fan, D. Biotransformation of ginsenoside Rb1 to ginsenoside CK by strain XD101: A safe bioconversion strategy. Appl. Biochem. Biotechnol. 2021, 193, 2110–2127. [Google Scholar] [CrossRef]
- Kim, S.A.; Jeong, E.B.; Oh, D.K. Complete bioconversion of protopanaxadiol-type ginsenosides to compound K by extracellular enzymes from the isolated strain Aspergillus tubingensis. J. Agric. Food Chem. 2021, 69, 315–324. [Google Scholar] [CrossRef]
- Kim, D.W.; Lee, W.J.; Gebru, Y.A.; Upadhyaya, J.; Ko, S.R.; Kim, Y.H.; Kim, M.K. Production of minor ginsenosides C-K and C-Y from naturally occurring major ginsenosides using crude β-glucosidase preparation from submerged culture of Fomitella fraxinea. Mol. 2021, 26, 4820. [Google Scholar] [CrossRef]
- Ku, S. Finding and Producing probiotic glycosylases for the biocatalysis of ginsenosides: A mini review. Molecules 2016, 21, 645. [Google Scholar] [CrossRef]
- Sorensen, A.; Lubeck, M.; Lubeck, P.S.; Ahring, B.K. Fungal beta-glucosidases: A bottleneck in industrial use of lignocellulosic materials. Biomolecules 2013, 3, 612–631. [Google Scholar] [CrossRef] [Green Version]
- Yan, Q.; Zhou, X.W.; Zhou, W.; Li, X.W.; Feng, M.Q.; Zhou, P. Purification and properties of a novel beta-glucosidase, hydrolyzing ginsenoside Rb1 to CK, from Paecilomyces Bainier. J. Microbiol. Biotechnol. 2008, 18, 1081–1089. [Google Scholar]
- Liu, C.Y.; Zhou, R.X.; Sun, C.K.; Jin, Y.H.; Yu, H.S.; Zhang, T.Y.; Xu, L.Q.; Jin, F.X. Preparation of minor ginsenosides C-Mc, C-Y, F2, and C-K from American ginseng PPD-ginsenoside using special ginsenosidase type-I from Aspergillus niger g.848. J. Ginseng Res. 2015, 39, 221–229. [Google Scholar] [CrossRef] [Green Version]
- Kim, H.W.; Han, S.H.; Lee, S.W.; Choi, H.S.; Suh, H.J.; Hong, K.B. Enzymatic hydrolysis increases ginsenoside content in Korean red ginseng (Panax ginseng CA Meyer) and its biotransformation under hydrostatic pressure. J. Sci. Food Agric. 2019, 99, 6806–6813. [Google Scholar] [CrossRef]
- Zheng, Y.; Zheng, Z.; Ming, Y.; Bai, Y.; Chen, L.; Huang, W.; Lin, M.; Liu, S.; Xiao, J.; Lin, H. Compound K producing from the enzymatic conversion of gypenoside by naringinase. Food Chem. Toxicol. 2019, 130, 253–261. [Google Scholar] [CrossRef]
- Pontrelli, S.; Chiu, T.Y.; Lan, E.I.; Chen, F.Y.; Chang, P.; Liao, J.C. Escherichia coli as a host for metabolic engineering. Metab. Eng. 2018, 50, 16–46. [Google Scholar] [CrossRef] [Green Version]
- Park, S.Y.; Bae, E.A.; Sung, J.H.; Lee, S.K.; Kim, D.H. Purification and characterization of ginsenoside Rb1-metabolizing beta-glucosidase from Fusobacterium K-60, a human intestinal anaerobic bacterium. Biosci. Biotechnol. Biochem. 2001, 65, 1163–1169. [Google Scholar] [CrossRef] [PubMed]
- An, D.S.; Cui, C.H.; Lee, H.G.; Wang, L.; Kim, S.C.; Lee, S.T.; Jin, F.; Yu, H.; Chiin, Y.W.; Lee, H.K.; et al. Identification and characterization of a novel Terrabacter ginsenosidimutans sp. nov. beta-glucosidase that transforms ginsenoside Rb1 into the rare gypenosides XVII and LXXV. Appl. Environ. Microbiol. 2010, 76, 5827–5836. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Quan, L.H.; Min, J.W.; Jin, Y.; Wang, C.; Kim, Y.J.; Yang, D.C. Enzymatic biotransformation of ginsenoside Rb1 to compound K by recombinant β-glucosidase from Microbacterium esteraromaticum. J. Agric. Food Chem. 2012, 60, 3776–3781. [Google Scholar] [CrossRef] [PubMed]
- Quan, L.H.; Jin, Y.; Wang, C.; Min, J.W.; Kim, Y.J.; Yang, D.C. Enzymatic transformation of the major ginsenoside Rb2 to minor compound Y and compound K by a ginsenoside-hydrolyzing β-glycosidase from Microbacterium esteraromaticum. J. Ind. Microbiol. Biotechnol. 2012, 39, 1557–1562. [Google Scholar] [CrossRef]
- Zhang, R.; Huang, X.M.; Yan, H.J.; Liu, X.Y.; Zhou, Q.; Luo, Z.Y.; Tan, X.N.; Zhang, B.L. Highly selective production of compound K from Ginsenoside Rd by hydrolyzing glucose at C-3 glycoside using β-Glucosidase of Bifidobacterium breve ATCC 15700. J. Microbiol. Biotechnol. 2019, 29, 410–418. [Google Scholar] [CrossRef] [Green Version]
- Noh, K.H.; Oh, D.K. Production of the rare ginsenosides compound K, compound Y, and compound Mc by a thermostable beta-glycosidase from Sulfolobus acidocaldarius. Biol. Pharm. Bull. 2009, 32, 1830–1835. [Google Scholar] [CrossRef] [Green Version]
- Yoo, M.H.; Yeom, S.J.; Park, C.S.; Lee, K.W.; Oh, D.K. Production of aglycon protopanaxadiol via compound K by a thermostable β-glycosidase from Pyrococcus furiosus. Appl. Microbiol. Biotechnol. 2011, 89, 1019–1028. [Google Scholar] [CrossRef]
- Shin, K.C.; Oh, H.J.; Kim, B.J.; Oh, D.K. Complete conversion of major protopanaxadiol ginsenosides to compound K by the combined use of α-L-arabinofuranosidase and β-galactosidase from Caldicellulosiruptor saccharolyticus and β-glucosidase from Sulfolobus acidocaldarius. J. Biotechnol. 2013, 167, 33–40. [Google Scholar] [CrossRef]
- Song, W.S.; Kim, M.J.; Shin, K.C.; Oh, D.K. Increased production of ginsenoside compound K by optimizing the feeding of American ginseng extract during fermentation by Aspergillus tubingensis. J. Microbiol. Biotechnol. 2022, 32, 902–910. [Google Scholar] [CrossRef]
- Noh, K.H.; Son, J.W.; Kim, H.J.; Oh, D.K. Ginsenoside compound K production from ginseng root extract by a thermostable beta-glycosidase from Sulfolobus solfataricus. Biosci. Biotechnol. Biochem. 2009, 73, 316–321. [Google Scholar] [CrossRef]
- Kim, E.H.; Lim, S.; Kim, S.O.; Ahn, S.H.; Choi, Y.J. Optimization of enzymatic treatment for compound K production from white ginseng extract by response surface methodology. Biosci. Biotechnol. Biochem. 2013, 77, 1138–1140. [Google Scholar] [CrossRef]
- Li, L.; Lee, S.J.; Yuan, Q.P.; Im, W.T.; Kim, S.C.; Han, N.S. Production of bioactive ginsenoside Rg3(S) and compound K using recombinant Lactococcus lactis. J. Ginseng Res. 2018, 42, 412–418. [Google Scholar] [CrossRef]
- Wang, P.; Tang, C.; Liu, Y.; Yang, J.; Fan, D. Biotransformation of high concentrations of ginsenoside substrate into compound K by β-glycosidase from Sulfolobus solfataricus. Genes 2023, 14, 897. [Google Scholar] [CrossRef]
- Akao, T.; Kida, H.; Kanaoka, M.; Hattori, M.; Kobashi, K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 1998, 50, 1155–1160. [Google Scholar] [CrossRef]
- Shen, H.; Leung, W.I.; Ruan, J.Q.; Li, S.L.; Lei, J.P.; Wang, Y.T.; Yan, R. Biotransformation of ginsenoside Rb1 via the gypenoside pathway by human gut bacteria. Chin. Med. 2013, 8, 22. [Google Scholar] [CrossRef] [Green Version]
- Bae, E.A.; Choo, M.K.; Park, E.K.; Park, S.Y.; Shin, H.Y.; Kim, D.H. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol. Pharm. Bull. 2002, 25, 743–747. [Google Scholar] [CrossRef] [Green Version]
- Fu, Y.; Yin, Z.H.; Wu, L.P.; Yin, C.R. Biotransformation of ginsenoside Rb1 to ginsenoside C-K by endophytic fungus Arthrinium sp. GE 17-18 isolated from Panax ginseng. Lett. Appl. Microbiol. 2016, 63, 196–201. [Google Scholar]
- Luo, S.L.; Dang, L.Z.; Li, J.F.; Zou, C.G.; Zhang, K.Q.; Li, G.H. Biotransformation of saponins by endophytes isolated from Panax notoginseng. Chem. Biodivers. 2013, 10, 2021–2031. [Google Scholar] [CrossRef]
- Cui, L.; Wu, S.Q.; Zhao, C.A.; Yin, C.R. Microbial conversion of major ginsenosides in ginseng total saponins by Platycodon grandiflorum endophytes. J. Ginseng Res. 2016, 40, 366–374. [Google Scholar] [CrossRef] [Green Version]
- Leung, K.; Wong, A. Pharmacology of ginsenosides: A literature review. Chin. Med. 2010, 5, 20. [Google Scholar] [CrossRef] [Green Version]
- Hasegawa, H.; Sung, J.H.; Benno, Y. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med. 1997, 63, 436–440. [Google Scholar] [CrossRef] [PubMed]
- Wan, J.Y.; Liu, P.; Wang, H.Y.; Qi, L.W.; Wang, C.Z.; Li, P.; Yuan, C.S. Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry. J. Chromatogr. A 2013, 1286, 83–92. [Google Scholar] [CrossRef] [PubMed]
- Choi, M.K.; Jin, S.; Jeon, J.H.; Kang, W.Y.; Seong, S.J.; Yoon, Y.R.; Han, Y.H.; Song, I.S. Tolerability and pharmacokinetics of ginsenosides Rb1, Rb2, Rc, Rd, and compound K after single or multiple administration of red ginseng extract in human beings. J. Ginseng Res. 2020, 44, 229–237. [Google Scholar] [CrossRef] [PubMed]
- Kim, D.H. Gut microbiota-mediated pharmacokinetics of ginseng saponins. J. Ginseng Res. 2018, 42, 255–263. [Google Scholar] [CrossRef] [PubMed]
- Zhang, X.; Chen, S.; Duan, F.; Liu, A.; Li, S.; Zhong, W.; Sheng, W.; Chen, J.; Xu, J.; Xiao, S. Prebiotics enhance the biotransformation and bioavailability of ginsenosides in rats by modulating gut microbiota. J. Ginseng Res. 2021, 45, 334–343. [Google Scholar] [CrossRef]
- Jeon, J.H.; Kang, B.; Lee, S.; Jin, S.; Choi, M.K.; Song, I.S. Pharmacokinetics and intestinal metabolism of compound K in rats and mice. Pharmaceutics 2020, 12, 129. [Google Scholar] [CrossRef] [Green Version]
- Zhang, M.; Wang, Y.; Wu, Y.; Li, F.; Han, M.; Dai, Y.; Zheng, F.; Yue, H. In Vitro Transformation of protopanaxadiol saponins in human intestinal flora and its effect on intestinal flora. Evid. Based Complement. Alternat. Med. 2021, 2021, 1735803. [Google Scholar] [CrossRef]
- Choi, J.R.; Hong, S.W.; Kim, Y.; Jang, S.E.; Kim, N.J.; Han, M.J.; Kim, D.H. Metabolic activities of ginseng and its constituents, ginsenoside rb1 and rg1, by human intestinal microflora. J. Ginseng Res. 2011, 35, 301–307. [Google Scholar] [CrossRef] [Green Version]
- Murthy, H.N.; Dalawai, D.; Park, S.Y.; Paek, K.Y. Endophytes of ginseng. In Endophytes and Secondary Metabolites; Jha, S., Ed.; Reference Series in Phytochemistry; Springer: Cham, Switzerland, 2019; pp. 165–186. [Google Scholar]
- Lu, J.; Wang, J.; Zhang, J.; Zhu, Y.; Qin, L.; Zhu, B. Diversity of culturable endophytic fungi in Crocus sativus and their correlation with crocin content. Curr. Microbiol. 2023, 80, 73. [Google Scholar] [CrossRef]
- Kandasamy, G.D.; Kathirvel, P. Insights into bacterial endophytic diversity and isolation with a focus on their potential applications—A review. Microbiol. Res. 2023, 266, 127256. [Google Scholar] [CrossRef]
- Wei, G.; Chen, Z.; Wang, B.; Wei, F.; Zhang, G.; Wang, Y.; Chen, S. Endophytes isolated from Panax notoginseng converted ginsenosides. Microb. Biotechnol. 2021, 14, 1730–1746. [Google Scholar] [CrossRef]
- Yao, L.; Wang, J.; He, J.; Huang, L.; Gao, W. Endophytes, biotransforming microorganisms, and engineering microbial factories for triterpenoid saponins production. Crit. Rev. Biotechnol. 2021, 41, 249–272. [Google Scholar] [CrossRef]
- Singh, A.; Singh, D.K.; Kharwar, R.N.; White, J.F.; Gond, S.K. Fungal endophytes as efficient sources of plant-derived bioactive compounds and their prospective applications in natural product drug discovery: Insights, avenues, and challenges. Microorganisms 2021, 9, 197. [Google Scholar] [CrossRef]
- Katsuyama, Y.; Funa, N.; Miyahisa, I.; Horinouchi, S. Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli. Chem. Biol. 2007, 14, 613–621. [Google Scholar] [CrossRef] [Green Version]
- Engels, B.; Dahm, P.; Jennewein, S. Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production. Metab. Eng. 2008, 10, 201–206. [Google Scholar] [CrossRef]
- Biggs, B.W.; Lim, C.G.; Sagliani, K.; Shankar, S.; Stephanopoulos, G.; De Mey, M.; Ajikumar, P.K. Overcoming heterologous protein interdependency to optimize P450-mediated Taxol precursor synthesis in Escherichia coli. Proc. Natl. Acad. Sci. USA 2016, 113, 3209–3214. [Google Scholar] [CrossRef]
- Ro, D.K.; Paradise, E.M.; Ouellet, M.; Fisher, K.J.; Newman, K.L.; Ndungu, J.M.; Ho, K.A.; Eachus, R.A.; Ham, T.S.; Kirby, J.; et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440, 940–943. [Google Scholar] [CrossRef]
- Zhang, C.; Hong, K. Production of terpenoids by synthetic biology approaches. Front. Bioeng. Biotechnol. 2020, 8, 347. [Google Scholar] [CrossRef]
- Wang, C.; Liwei, M.; Park, J.B.; Jeong, S.H.; Wei, G.; Wang, Y.; Kim, S.W. Microbial platform for terpenoid Production: Escherichia coli and Yeast. Front. Microbiol. 2018, 9, 2460. [Google Scholar] [CrossRef]
- Yan, X.; Fan, Y.; Wei, W.; Wang, P.; Liu, Q.; Wei, Y.; Zhang, L.; Zhao, G.; Yue, J.; Zhou, Z. Production of bioactive ginsenoside compound K in metabolically engineered yeast. Cell Res. 2014, 24, 770–773. [Google Scholar] [CrossRef]
- Wei, W.; Wang, P.; Wei, Y.; Liu, Q.; Yang, C.; Zhao, G.; Zhou, Z. Characterization of Panax ginseng UDP-Glycosyltransferases catalyzing protopanaxatriol and biosyntheses of bioactive ginsenosides F1 and Rh1 in metabolically engineered yeasts. Mol. Plant Pathol. 2015, 8, 1412–1424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nan, W.; Zhao, F.; Zhang, C.; Ju, H.; Lu, W. Promotion of compound K production in Saccharomyces cerevisiae by glycerol. Microb. Cell Fact. 2020, 19, 41. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, P.; Wang, J.; Zhao, G.; Yan, X.; Zhou, Z. Systematic optimization of the yeast cell factory for sustainable and high efficiency production of bioactive ginsenoside compound K. Synth. Syst. Biotechnol. 2021, 6, 69–76. [Google Scholar] [CrossRef] [PubMed]
- Shi, Y.; Wang, D.; Li, R.; Huang, L.; Dai, Z.; Zhang, X. Engineering yeast subcellular compartments for increased production of the lipophilic natural products ginsenosides. Metab. Eng. 2021, 67, 104–111. [Google Scholar] [CrossRef] [PubMed]
- Kavscek, M.; Bhutada, G.; Madl, T.; Natter, K. Optimization of lipid production with a genome-scale model of Yarrowia lipolytica. BMC Syst Biol. 2015, 9, 72. [Google Scholar] [CrossRef] [Green Version]
- Bosio, M.C.; Negri, R.; Dieci, G. Promoter architectures in the yeast ribosomal expression program. Transcription 2011, 2, 71–77. [Google Scholar] [CrossRef] [Green Version]
- Peng, B.; Williams, T.C.; Henry, M.; Nielsen, L.K.; Vickers, C.E. Controlling heterologous gene expression in yeast cell factories on different carbon substrates and across the diauxic shift: A comparison of yeast promoter activities. Microb. Cell Fact. 2015, 14, 91. [Google Scholar] [CrossRef] [Green Version]
- Rajkumar, A.S.; Ozdemir, E.; Lis, A.V.; Schneider, K.; Qin, J.; Jensen, M.K.; Keasling, J.D. Engineered reversal of function in glycolytic yeast promoters. ACS Synth. Biol. 2019, 8, 1462–1468. [Google Scholar] [CrossRef]
- Hubmann, G.; Thevelein, J.M.; Nevoigt, E. Natural and modified promoters for tailored metabolic engineering of the yeast Saccharomyces cerevisiae. Methods Mol. Biol. 2014, 1152, 17–42. [Google Scholar]
- Liu, Q.; Yu, T.; Li, X.; Chen, Y.; Campbell, K.; Nielsen, J.; Chen, Y. Rewiring carbon metabolism in yeast for high level production of aromatic chemicals. Nat. Commun. 2019, 10, 4976. [Google Scholar] [CrossRef] [Green Version]
- Dai, Z.; Wang, B.; Liu, Y.; Shi, M.; Wang, D.; Zhang, X.; Liu, T.; Huang, L.; Zhang, X. Producing aglycons of ginsenosides in bakers’ yeast. Sci. Rep. 2014, 4, 3698. [Google Scholar] [CrossRef] [Green Version]
- Giri, S.; Schmidt-Heck, W.; Bader, A. Improved metabolic pathways of glycolysis, glycogen synthesis, the urea cycle, and cytochrome peroxidase oxidative reabsorption in a miniature bioreactor. Cell. Physiol. Biochem. 2022, 56, 209–222. [Google Scholar]
- Mekoue Nguela, J.; Teuf, O.; Assuncao Bicca, S.; Vernhet, A. Impact of mannoprotein N-glycosyl phosphorylation and branching on the sorption of wine polyphenols by yeasts and yeast cell walls. Food Chem. 2023, 403, 134326. [Google Scholar] [CrossRef]
- Zhao, W.; Hang, B.; Zhu, X.; Wang, R.; Shen, M.; Huang, L.; Xu, Z. Improving the productivity of S-adenosyl-l-methionine by metabolic engineering in an industrial Saccharomyces cerevisiae strain. J. Biotechnol. 2016, 236, 64–70. [Google Scholar] [CrossRef]
- Chhetri, A.; Loksztejn, A.; Nguyen, H.; Pianalto, K.M.; Kim, M.J.; Hong, J.; Alspaugh, J.A.; Yokoyama, K. Length specificity and polymerization mechanism of (1,3)-β-d-glucan synthase in fungal cell wall biosynthesis. Biochemistry 2020, 59, 682–693. [Google Scholar] [CrossRef]
- Choi, B.H.; Kang, H.J.; Kim, S.C.; Lee, P.C. Organelle engineering in yeast: Enhanced production of protopanaxadiol through manipulation of peroxisome proliferation in Saccharomyces cerevisiae. Microorganisms 2022, 10, 650. [Google Scholar] [CrossRef]
- Chen, L.; Xiao, W.; Yao, M.; Wang, Y.; Yuan, Y. Compartmentalization engineering of yeasts to overcome precursor limitations and cytotoxicity in terpenoid production. Front. Bioeng. Biotechnol. 2023, 11, 1132244. [Google Scholar] [CrossRef]
- Kircher, M. Bioeconomy—Present status and future needs of industrial value chains. N. Biotechnol. 2020, 60, 96–104. [Google Scholar] [CrossRef]
- Busic, A.; Marđetko, N.; Kundas, S.; Morzak, G.; Belskaya, H.; Ivančić Šantek, M.; Komes, D.; Novak, S.; Šantek, B. Bioethanol production from renewable raw materials and its separation and purification: A Review. Food Technol. Biotechnol. 2018, 56, 289–311. [Google Scholar] [CrossRef]
- Xu, G.; Li, H.; Xing, W.; Gong, L.; Dong, J.; Ni, Y. Facilely reducing recalcitrance of lignocellulosic biomass by a newly developed ethylamine-based deep eutectic solvent for biobutanol fermentation. Biotechnol. Biofuels 2020, 13, 166. [Google Scholar] [CrossRef]
- Ochoa-Estopier, A.; Lesage, J.; Gorret, N.; Guillouet, S.E. Kinetic analysis of a Saccharomyces cerevisiae strain adapted for improved growth on glycerol: Implications for the development of yeast bioprocesses on glycerol. Bioresour. Technol. 2011, 102, 1521–1527. [Google Scholar] [CrossRef] [PubMed]
- Truniger, V.; Boos, W. Glycerol uptake in Escherichia coli is sensitive to membrane lipid composition. Res. Microbiol. 1993, 144, 565–574. [Google Scholar] [CrossRef] [PubMed]
- LaConte, L.E.; Chavan, V.; Mukherjee, K. Identification and glycerol-induced correction of misfolding mutations in the X-linked mental retardation gene CASK. PLoS ONE 2014, 9, e88276. [Google Scholar] [CrossRef] [PubMed]
- Dutra, M.B.; Silva, J.T.; Mattos, D.C.; Panek, A.D. Regulation of UDPG-pyrophosphorylase isoforms in Saccharomyces cerevisiae and their roles in trehalose metabolism. Biochim. Biophys. Acta. 1996, 1289, 261–269. [Google Scholar] [CrossRef]
- Aßkamp, M.R.; Klein, M.; Nevoigt, E. Saccharomyces cerevisiae exhibiting a modified route for uptake and catabolism of glycerol forms significant amounts of ethanol from this carbon source considered as ‘non-fermentable’. Biotechnol. Biofuels 2019, 12, 257. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Abdel-Mawgoud, A.M.; Markham, K.A.; Palmer, C.M.; Liu, N.; Stephanopoulos, G.; Alper, H.S. Metabolic engineering in the host Yarrowia lipolytica. Metab. Eng. 2018, 50, 192–208. [Google Scholar] [CrossRef]
- Ma, Y.R.; Wang, K.F.; Wang, W.J.; Ding, Y.; Shi, T.Q.; Huang, H.; Ji, X.J. Advances in the metabolic engineering of Yarrowia lipolytica for the production of terpenoids. Bioresour. Technol. 2019, 281, 449–456. [Google Scholar] [CrossRef]
- Spagnuolo, M.; Shabbir Hussain, M.; Gambill, L.; Blenner, M. Alternative substrate metabolism in Yarrowia lipolytica. Front. Microbiol. 2018, 9, 1077. [Google Scholar] [CrossRef] [Green Version]
- Li, D.; Wu, Y.; Zhang, C.; Sun, J.; Zhou, Z.; Lu, W. Production of triterpene ginsenoside compound K in the non-conventional yeast Yarrowia lipolytica. J. Agric. Food Chem. 2019, 67, 2581–2588. [Google Scholar] [CrossRef]
- Cao, X.; Lv, Y.B.; Chen, J.; Imanaka, T.; Wei, L.J.; Hua, Q. Metabolic engineering of oleaginous yeast Yarrowia lipolytica for limonene overproduction. Biotechnol. Biofuels 2016, 9, 214. [Google Scholar] [CrossRef] [Green Version]
- Cao, X.; Wei, L.J.; Lin, J.Y.; Hua, Q. Enhancing linalool production by engineering oleaginous yeast Yarrowia lipolytica. Bioresour. Technology 2017, 245, 1641–1644. [Google Scholar] [CrossRef] [PubMed]
- Guo, X.; Sun, J.; Li, D.; Lu, W. Heterologous biosynthesis of (+)-nootkatone in unconventional yeast Yarrowia lipolytica. Biochem. Eng. J. 2018, 137, 125–131. [Google Scholar] [CrossRef]
- Zhao, C.; Gao, Q.; Chen, J.; Wei, L.; Imanaka, T.; Hua, Q. Metabolomic changes and metabolic responses to expression of heterologous biosynthetic genes for lycopene production in Yarrowia lipolytica. J. Biotechnol. 2017, 251, 174–185. [Google Scholar] [CrossRef] [PubMed]
- Larroude, M.; Celinska, E.; Back, A.; Thomas, S.; Nicaud, J.M.; Ledesma-Amaro, R. A synthetic biology approach to transform Yarrowia lipolytica into a competitive biotechnological producer of β-carotene. Biotechnol. Bioeng. 2018, 115, 464–472. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Structure | Name | R1 | R2 | R3 | R4 |
---|---|---|---|---|---|
Protopanaxadiol (PPD) Type | |||||
CK | H | - | Glc | - | |
CO | Glc | - | Glc6-Ara(p) | - | |
CY | H | - | Glc6-Ara(p) | - | |
CMc | H | - | Glc6-Ara(f) | - | |
CMc1 | Glc | - | Glc6-Ara(f) | - | |
CMx | H | - | Glc6-Xyl | - | |
CMx1 | Glc | - | Glc6-Xyl | - | |
Gyp XVII | Glc | - | Glc6-Glc | - | |
Gyp LXXV | H | - | Glc6-Glc | - | |
F2 | Glc | - | Glc | - | |
Rh2 | Glc | - | H | - | |
Rg3 | Glc2-Glc | - | H | - | |
Rd | Glc2-Glc | - | Glc | - | |
Rc | Glc2-Glc | - | Glc6-Ara(f) | - | |
Rb3 | Glc2-Glc | - | Glc6-Xyl | - | |
Rb2 | Glc2-Glc | - | Glc6-Ara(p) | - | |
Rb1 | Glc2-Glc | - | Glc6-Glc | - | |
Ra1 | Glc2-Glc | - | Glc6-Ara(p)4-Xyl | - | |
Protopanaxatriol (PPT)-type | |||||
F1 | OH | H | Glc | - | |
Rh1 | OH | Glc | H | - | |
Rg2 | OH | Glc2-Rha | H | - | |
Rg1 | OH | Glc | Glc | - | |
Rf | OH | Glc2-Glc | H | - | |
Re | OH | Glc2-Rha | Glc | - | |
PPT | OH | H | H | - | |
Ocotillol-type | |||||
Vinaginsenoside R1 | OH | Ac-Glc2-Rha | - | - | |
Majonoside R2 | OH | Glc2-Xyl | - | - | |
Oleanolic acid type | |||||
ROA | GlcUA-Glc | - | - | Glc6-Glc | |
RO | GlcUA-Glc | - | - | Glc |
Strains | Related Gene Cassettes in Biosynthesis Pathway | Titer | Major Media | Carbon Source | Cultivation Condition | Ref. |
---|---|---|---|---|---|---|
Saccharomyces cerevisiae | ||||||
BK1 (BA21) | ERG1, PgDDS, PgCYP716A47, AtATR2-1, UGT71A28 | 155.4 (μg L−1) | SC | Glucose | Shake-flask | [101] |
BKE | AtATR2-1, UGT71A28, PgCYP716A47, ERG1, PgDDS, tHMGR-UPC2.1 | 802.1 (μg L−1) | ||||
AKE | ERG1, PgDDS, PgCYP716A47, AtATR2-1, UGT71A28 | 243.8 (μg L−1) | Galactose | |||
AK1 | AtATR2-1, UGT71A28, PgCYP716A47, ERG1, PgDDS, tHMGR-UPC2.1 | 1424.8 (μg L−1) | ||||
ZW-F1-17 | ERG20, PgERG1, ERG9, tHMG1, CYP716A53v2, PgCPR1, UGTPg1 | 7.5 (μg L−1) | SC | Glucose | Shake-flask | [102] |
WLN-3 | DS, PPDS-ATR1, ERG1, tHMGR, ERG9, ERG20, ERG10, ERG13, ERG12, ERG8, ERG19, IDI1, NCP1, ACSseL641P, TetR, PGM2 and UGP1, PgUGP1 | 263.94 (mg L−1) | YPD | Glucose | Shake-flask | [103] |
WLN-3 | DS, PPDS-ATR1, ERG1, tHMGR, ERG9, ERG20, ERG10, ERG13, ERG12, ERG8, ERG19, IDI1, NCP1, ACSseL641P, TetR, PGM2 and UGP1, PgUGP1 | 384.52 (mg L−1) | YPDG (20%) | Glucose, glycerol | Shake-flask | |
WPK12 | ERG10, ERG13, tHMG1, ERG12, ERG8, ERG19, IDI1, ERG20, ERG9, ERG1, PgDDS, PgPPDS, PgCPR1, synUGTPg1, PGM2, URA6, YNK1, ΔAGL5 | 5.74 (g L−1) | YPD | Glucose | Fed batch | [104] |
LPTA-M | ERG12, tHMG1, ERG13, ERG10, ERG8, ERG19 IDI1, AtSQS2, ERG1, SmFPS, SynPgPPDS, ATR1, PLN1 | 5.0 (g L−1) | SD | Glucose | Shake-flask | [105] |
Yarrowia lipolytica | ||||||
YL-MVA-CK | tHMG1, ERG9, ERG20, opDS, PPDS linker2-ATR1, UGT1 | 161.8 (mg L−1) | YPD | Glucose | Fed batch | [106] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chu, L.L.; Hanh, N.T.Y.; Quyen, M.L.; Nguyen, Q.H.; Lien, T.T.P.; Do, K.V. Compound K Production: Achievements and Perspectives. Life 2023, 13, 1565. https://doi.org/10.3390/life13071565
Chu LL, Hanh NTY, Quyen ML, Nguyen QH, Lien TTP, Do KV. Compound K Production: Achievements and Perspectives. Life. 2023; 13(7):1565. https://doi.org/10.3390/life13071565
Chicago/Turabian StyleChu, Luan Luong, Nguyen Trinh Yen Hanh, My Linh Quyen, Quang Huy Nguyen, Tran Thi Phuong Lien, and Khanh Van Do. 2023. "Compound K Production: Achievements and Perspectives" Life 13, no. 7: 1565. https://doi.org/10.3390/life13071565